Apixaban and Eftrenonacog Alfa Treatment in a Patient with Moderate Hemophilia B and Cardiovascular Disease
Abstract
Share and Cite
Santoro, R.C.; Falbo, M.; Ferraro, A. Apixaban and Eftrenonacog Alfa Treatment in a Patient with Moderate Hemophilia B and Cardiovascular Disease. Hematol. Rep. 2021, 13, 9169. https://doi.org/10.4081/hr.2021.9169
Santoro RC, Falbo M, Ferraro A. Apixaban and Eftrenonacog Alfa Treatment in a Patient with Moderate Hemophilia B and Cardiovascular Disease. Hematology Reports. 2021; 13(3):9169. https://doi.org/10.4081/hr.2021.9169
Chicago/Turabian StyleSantoro, Rita C., Mariapia Falbo, and Alessandro Ferraro. 2021. "Apixaban and Eftrenonacog Alfa Treatment in a Patient with Moderate Hemophilia B and Cardiovascular Disease" Hematology Reports 13, no. 3: 9169. https://doi.org/10.4081/hr.2021.9169